BASF increases prices for Vitamin E and A feed grade
Advertisement
BASF increases prices for vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all vitamin A products. Existing contractual obligations with customers will be honored.
Most read news
Organizations
Other news from the department price development
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Cell Medica granted Orphan Drug designation for novel cellular therapy
Drug costs vary by more than 600% in study of 10 high-income countries
Are the high prices of cancer drugs justified? - Does the cost correspond to the particular drug’s effectiveness in combating the disease?
NextPharma inaugurates new production facility for liquid pharmaceuticals in Limay, France - "This project reflects our commitment to bringing the production of essential medicines back to France..."
Spanish startup receives investment for novel disinfection method against “killer fungus” - The UJI spin-off Molecular Sustainable Solutions receives an investment from BeAble Capital to boost its disinfection and sterilization methods
Merck Opens Climate-Neutral €150 Million Manufacturing Facility in Ireland - The Blarney Business Park facility is part of Merck’s largest Life Science investment to date
Simtra BioPharma Solutions expands U.S. manufacturing capacity for injectable medicines - Simtra positioned to become the first CDMO to offer commercial-scale drug product manufacturing of antibody-drug conjugates in the United States
CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE
ChatGPT grows insect-toxic genetically engineered plant - Blind spot in the EU draft law on genetic engineering
Commission launches new strategy to make Europe a global leader in life sciences by 2030
CureVac Announces Resolution of Patent Litigation with Pfizer/BioNTech - BioNTech’s acquisition of CureVac will be implemented as planned